Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

• Status: Not yet recruiting
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare over the counter and alternative prescription urinary alkalinizing agents to slow release potassium citrate in their ability to modify urinary parameters associated with stone formation.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Texas Southwestern Medical Center
• Treatments: Potassium Citrate

Criteria

Inclusion Criteria:

• Adults aged 18 and older.

• with or without a history of stone disease.

Exclusion Criteria:

• They are unable to take any of the medications due to health reasons.

• Participants are pregnant or nursing.

• Participants are unable to adhere to the metabolic diet.

• Participants had a prior adverse event from one or more of the medications.